April 7, 2023

Detailing RAAS Therapy in Heart, Kidney Disease Patients

In an APhA2022 education session presented titled “Back to Basics: Not Talkin’ tRAASh,” Joe Saseen, PharmD, BCSP, BCACP, FAPhA, focused on the renin-angiotensin-aldosterone system (RAAS) system, its effect on blood pressure regulation, and the benefits and risk of the drugs that block this system. He emphasized how RAAS therapy is beneficial in patients with kidney and heart disease. Read more.